nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—colon cancer	0.396	1	CbGaD
Midazolam—CYP3A7—Irinotecan—colon cancer	0.0577	0.128	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0577	0.128	CbGbCtD
Midazolam—CYP2B6—Irinotecan—colon cancer	0.0549	0.122	CbGbCtD
Midazolam—CYP3A7—Vincristine—colon cancer	0.0504	0.112	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0504	0.112	CbGbCtD
Midazolam—CYP3A5—Irinotecan—colon cancer	0.0433	0.0958	CbGbCtD
Midazolam—CYP3A5—Vincristine—colon cancer	0.0378	0.0838	CbGbCtD
Midazolam—ABCB1—Irinotecan—colon cancer	0.0282	0.0624	CbGbCtD
Midazolam—ABCB1—Vincristine—colon cancer	0.0246	0.0545	CbGbCtD
Midazolam—CYP3A4—Irinotecan—colon cancer	0.0169	0.0374	CbGbCtD
Midazolam—ABCB1—Methotrexate—colon cancer	0.0149	0.033	CbGbCtD
Midazolam—CYP3A4—Vincristine—colon cancer	0.0147	0.0327	CbGbCtD
Midazolam—Salivation—Irinotecan—colon cancer	0.00331	0.023	CcSEcCtD
Midazolam—Miosis—Irinotecan—colon cancer	0.00307	0.0213	CcSEcCtD
Midazolam—Obstructive airways disorder—Methotrexate—colon cancer	0.00281	0.0196	CcSEcCtD
Midazolam—Application site pain—Fluorouracil—colon cancer	0.00279	0.0194	CcSEcCtD
Midazolam—Slurred speech—Fluorouracil—colon cancer	0.00274	0.0191	CcSEcCtD
Midazolam—Local reaction—Fluorouracil—colon cancer	0.00222	0.0154	CcSEcCtD
Midazolam—Depressed mood—Capecitabine—colon cancer	0.00192	0.0133	CcSEcCtD
Midazolam—Nystagmus—Vincristine—colon cancer	0.00184	0.0128	CcSEcCtD
Midazolam—Skin necrosis—Methotrexate—colon cancer	0.00183	0.0127	CcSEcCtD
Midazolam—Thrombosis—Irinotecan—colon cancer	0.00181	0.0126	CcSEcCtD
Midazolam—Nystagmus—Fluorouracil—colon cancer	0.00172	0.012	CcSEcCtD
Midazolam—Sneezing—Capecitabine—colon cancer	0.00155	0.0108	CcSEcCtD
Midazolam—Tenderness—Fluorouracil—colon cancer	0.00141	0.00978	CcSEcCtD
Midazolam—Haematoma—Capecitabine—colon cancer	0.00136	0.00949	CcSEcCtD
Midazolam—Dysarthria—Irinotecan—colon cancer	0.00135	0.00942	CcSEcCtD
Midazolam—Respiratory failure—Vincristine—colon cancer	0.00134	0.00932	CcSEcCtD
Midazolam—Dysarthria—Fluorouracil—colon cancer	0.0013	0.00903	CcSEcCtD
Midazolam—Hiccups—Irinotecan—colon cancer	0.00128	0.00891	CcSEcCtD
Midazolam—Salivary hypersecretion—Irinotecan—colon cancer	0.00124	0.00866	CcSEcCtD
Midazolam—Thrombosis—Capecitabine—colon cancer	0.00121	0.00843	CcSEcCtD
Midazolam—Fracture—Methotrexate—colon cancer	0.0011	0.00764	CcSEcCtD
Midazolam—Multiple fractures—Methotrexate—colon cancer	0.0011	0.00764	CcSEcCtD
Midazolam—Thrombophlebitis—Irinotecan—colon cancer	0.00107	0.00747	CcSEcCtD
Midazolam—Rhinorrhoea—Capecitabine—colon cancer	0.00106	0.00736	CcSEcCtD
Midazolam—Euphoric mood—Fluorouracil—colon cancer	0.00105	0.00733	CcSEcCtD
Midazolam—Injection site pain—Capecitabine—colon cancer	0.00105	0.00731	CcSEcCtD
Midazolam—Dysphonia—Capecitabine—colon cancer	0.00104	0.00725	CcSEcCtD
Midazolam—Thrombophlebitis—Fluorouracil—colon cancer	0.00103	0.00716	CcSEcCtD
Midazolam—Extrasystoles—Capecitabine—colon cancer	0.00102	0.00709	CcSEcCtD
Midazolam—Injury—Irinotecan—colon cancer	0.00101	0.00704	CcSEcCtD
Midazolam—Swelling—Fluorouracil—colon cancer	0.00101	0.00702	CcSEcCtD
Midazolam—Hypoxia—Methotrexate—colon cancer	0.00101	0.00699	CcSEcCtD
Midazolam—Disorientation—Fluorouracil—colon cancer	0.000996	0.00693	CcSEcCtD
Midazolam—Visual disturbance—Irinotecan—colon cancer	0.000982	0.00683	CcSEcCtD
Midazolam—Anaphylactoid reaction—Irinotecan—colon cancer	0.000961	0.00668	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Capecitabine—colon cancer	0.000956	0.00665	CcSEcCtD
Midazolam—Ventricular extrasystoles—Capecitabine—colon cancer	0.00095	0.0066	CcSEcCtD
Midazolam—Osteoarthritis—Irinotecan—colon cancer	0.00093	0.00647	CcSEcCtD
Midazolam—Cardiac failure—Fluorouracil—colon cancer	0.000913	0.00635	CcSEcCtD
Midazolam—Lethargy—Fluorouracil—colon cancer	0.000909	0.00632	CcSEcCtD
Midazolam—Cardiac arrest—Vincristine—colon cancer	0.000908	0.00632	CcSEcCtD
Midazolam—Dysarthria—Capecitabine—colon cancer	0.000907	0.00631	CcSEcCtD
Midazolam—Ataxia—Vincristine—colon cancer	0.000898	0.00625	CcSEcCtD
Midazolam—Osteoarthritis—Fluorouracil—colon cancer	0.000891	0.0062	CcSEcCtD
Midazolam—Cardiac arrest—Irinotecan—colon cancer	0.000885	0.00615	CcSEcCtD
Midazolam—Hiccups—Capecitabine—colon cancer	0.000858	0.00597	CcSEcCtD
Midazolam—Irritability—Fluorouracil—colon cancer	0.00085	0.00591	CcSEcCtD
Midazolam—Cardiac arrest—Fluorouracil—colon cancer	0.000847	0.00589	CcSEcCtD
Midazolam—Muscular weakness—Vincristine—colon cancer	0.000842	0.00586	CcSEcCtD
Midazolam—Ataxia—Fluorouracil—colon cancer	0.000838	0.00583	CcSEcCtD
Midazolam—Depressed level of consciousness—Capecitabine—colon cancer	0.000828	0.00576	CcSEcCtD
Midazolam—Skin exfoliation—Capecitabine—colon cancer	0.000819	0.0057	CcSEcCtD
Midazolam—Nasopharyngitis—Fluorouracil—colon cancer	0.000797	0.00554	CcSEcCtD
Midazolam—Muscular weakness—Fluorouracil—colon cancer	0.000786	0.00547	CcSEcCtD
Midazolam—Apnoea—Methotrexate—colon cancer	0.000753	0.00524	CcSEcCtD
Midazolam—Depression—Vincristine—colon cancer	0.000734	0.00511	CcSEcCtD
Midazolam—Phlebitis—Capecitabine—colon cancer	0.000723	0.00503	CcSEcCtD
Midazolam—Neuropathy peripheral—Vincristine—colon cancer	0.000722	0.00502	CcSEcCtD
Midazolam—Sleep disorder—Capecitabine—colon cancer	0.000719	0.005	CcSEcCtD
Midazolam—Thrombophlebitis—Capecitabine—colon cancer	0.000719	0.005	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Methotrexate—colon cancer	0.000712	0.00495	CcSEcCtD
Midazolam—Swelling—Capecitabine—colon cancer	0.000706	0.00491	CcSEcCtD
Midazolam—Dysarthria—Methotrexate—colon cancer	0.000675	0.0047	CcSEcCtD
Midazolam—UGT1A4—renal system—colon cancer	0.000675	0.0779	CbGeAlD
Midazolam—Neuropathy peripheral—Fluorouracil—colon cancer	0.000673	0.00468	CcSEcCtD
Midazolam—Hallucination—Vincristine—colon cancer	0.000657	0.00457	CcSEcCtD
Midazolam—Bradycardia—Irinotecan—colon cancer	0.000655	0.00456	CcSEcCtD
Midazolam—Respiratory failure—Methotrexate—colon cancer	0.00065	0.00452	CcSEcCtD
Midazolam—Connective tissue disorder—Vincristine—colon cancer	0.000649	0.00452	CcSEcCtD
Midazolam—Cardiac failure—Capecitabine—colon cancer	0.000638	0.00444	CcSEcCtD
Midazolam—Lethargy—Capecitabine—colon cancer	0.000635	0.00442	CcSEcCtD
Midazolam—Connective tissue disorder—Irinotecan—colon cancer	0.000632	0.0044	CcSEcCtD
Midazolam—Osteoarthritis—Capecitabine—colon cancer	0.000623	0.00433	CcSEcCtD
Midazolam—Diplopia—Capecitabine—colon cancer	0.000623	0.00433	CcSEcCtD
Midazolam—Visual impairment—Irinotecan—colon cancer	0.00062	0.00431	CcSEcCtD
Midazolam—Depressed level of consciousness—Methotrexate—colon cancer	0.000617	0.00429	CcSEcCtD
Midazolam—Cardiac disorder—Vincristine—colon cancer	0.000613	0.00427	CcSEcCtD
Midazolam—Skin exfoliation—Methotrexate—colon cancer	0.00061	0.00424	CcSEcCtD
Midazolam—Cardiac disorder—Irinotecan—colon cancer	0.000597	0.00415	CcSEcCtD
Midazolam—Mediastinal disorder—Vincristine—colon cancer	0.000596	0.00414	CcSEcCtD
Midazolam—Irritability—Capecitabine—colon cancer	0.000594	0.00413	CcSEcCtD
Midazolam—Cardiac arrest—Capecitabine—colon cancer	0.000592	0.00412	CcSEcCtD
Midazolam—Mood swings—Capecitabine—colon cancer	0.00059	0.0041	CcSEcCtD
Midazolam—Ataxia—Capecitabine—colon cancer	0.000585	0.00407	CcSEcCtD
Midazolam—Immune system disorder—Irinotecan—colon cancer	0.000581	0.00404	CcSEcCtD
Midazolam—Mediastinal disorder—Irinotecan—colon cancer	0.00058	0.00403	CcSEcCtD
Midazolam—Mental disorder—Vincristine—colon cancer	0.000579	0.00403	CcSEcCtD
Midazolam—Chills—Irinotecan—colon cancer	0.000577	0.00402	CcSEcCtD
Midazolam—Nasopharyngitis—Capecitabine—colon cancer	0.000557	0.00387	CcSEcCtD
Midazolam—UGT1A4—digestive system—colon cancer	0.000554	0.0639	CbGeAlD
Midazolam—Muscular weakness—Capecitabine—colon cancer	0.000549	0.00382	CcSEcCtD
Midazolam—CYP4B1—digestive system—colon cancer	0.000546	0.0631	CbGeAlD
Midazolam—Erythema—Fluorouracil—colon cancer	0.000537	0.00373	CcSEcCtD
Midazolam—Thrombophlebitis—Methotrexate—colon cancer	0.000535	0.00372	CcSEcCtD
Midazolam—Bronchospasm—Capecitabine—colon cancer	0.000529	0.00368	CcSEcCtD
Midazolam—Agitation—Vincristine—colon cancer	0.000529	0.00368	CcSEcCtD
Midazolam—Vertigo—Vincristine—colon cancer	0.000517	0.00359	CcSEcCtD
Midazolam—Vision blurred—Fluorouracil—colon cancer	0.000506	0.00352	CcSEcCtD
Midazolam—Vertigo—Irinotecan—colon cancer	0.000503	0.0035	CcSEcCtD
Midazolam—Syncope—Irinotecan—colon cancer	0.000502	0.00349	CcSEcCtD
Midazolam—Visual disturbance—Methotrexate—colon cancer	0.000489	0.0034	CcSEcCtD
Midazolam—Cough—Irinotecan—colon cancer	0.000489	0.0034	CcSEcCtD
Midazolam—CYP4B1—vagina—colon cancer	0.000483	0.0557	CbGeAlD
Midazolam—Anaphylactoid reaction—Methotrexate—colon cancer	0.000479	0.00333	CcSEcCtD
Midazolam—Depression—Capecitabine—colon cancer	0.000478	0.00333	CcSEcCtD
Midazolam—Lethargy—Methotrexate—colon cancer	0.000473	0.00329	CcSEcCtD
Midazolam—Neuropathy peripheral—Capecitabine—colon cancer	0.00047	0.00327	CcSEcCtD
Midazolam—Anaphylactic shock—Vincristine—colon cancer	0.000469	0.00327	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—colon cancer	0.000463	0.00322	CcSEcCtD
Midazolam—Confusional state—Irinotecan—colon cancer	0.000461	0.00321	CcSEcCtD
Midazolam—Nervous system disorder—Vincristine—colon cancer	0.00046	0.0032	CcSEcCtD
Midazolam—Anaphylactic shock—Irinotecan—colon cancer	0.000457	0.00318	CcSEcCtD
Midazolam—Shock—Irinotecan—colon cancer	0.00045	0.00313	CcSEcCtD
Midazolam—Nervous system disorder—Irinotecan—colon cancer	0.000448	0.00312	CcSEcCtD
Midazolam—Irritability—Methotrexate—colon cancer	0.000442	0.00308	CcSEcCtD
Midazolam—Confusional state—Fluorouracil—colon cancer	0.000442	0.00307	CcSEcCtD
Midazolam—Mood swings—Methotrexate—colon cancer	0.000439	0.00305	CcSEcCtD
Midazolam—Hypotension—Vincristine—colon cancer	0.000439	0.00305	CcSEcCtD
Midazolam—Bradycardia—Capecitabine—colon cancer	0.000438	0.00305	CcSEcCtD
Midazolam—Anaphylactic shock—Fluorouracil—colon cancer	0.000438	0.00305	CcSEcCtD
Midazolam—Ataxia—Methotrexate—colon cancer	0.000436	0.00303	CcSEcCtD
Midazolam—Nervous system disorder—Fluorouracil—colon cancer	0.000429	0.00299	CcSEcCtD
Midazolam—Tachycardia—Fluorouracil—colon cancer	0.000427	0.00297	CcSEcCtD
Midazolam—Hypotension—Irinotecan—colon cancer	0.000427	0.00297	CcSEcCtD
Midazolam—Connective tissue disorder—Capecitabine—colon cancer	0.000423	0.00294	CcSEcCtD
Midazolam—Paraesthesia—Vincristine—colon cancer	0.000422	0.00293	CcSEcCtD
Midazolam—Visual impairment—Capecitabine—colon cancer	0.000415	0.00289	CcSEcCtD
Midazolam—UGT1A4—liver—colon cancer	0.000412	0.0476	CbGeAlD
Midazolam—Paraesthesia—Irinotecan—colon cancer	0.000411	0.00286	CcSEcCtD
Midazolam—Hypotension—Fluorouracil—colon cancer	0.000409	0.00285	CcSEcCtD
Midazolam—Dyspnoea—Irinotecan—colon cancer	0.000408	0.00284	CcSEcCtD
Midazolam—Somnolence—Irinotecan—colon cancer	0.000406	0.00283	CcSEcCtD
Midazolam—Gastrointestinal disorder—Vincristine—colon cancer	0.000405	0.00282	CcSEcCtD
Midazolam—Fatigue—Vincristine—colon cancer	0.000405	0.00282	CcSEcCtD
Midazolam—Eye disorder—Capecitabine—colon cancer	0.000403	0.0028	CcSEcCtD
Midazolam—Dyspepsia—Irinotecan—colon cancer	0.000402	0.0028	CcSEcCtD
Midazolam—Pain—Vincristine—colon cancer	0.000401	0.00279	CcSEcCtD
Midazolam—Constipation—Vincristine—colon cancer	0.000401	0.00279	CcSEcCtD
Midazolam—Cardiac disorder—Capecitabine—colon cancer	0.0004	0.00278	CcSEcCtD
Midazolam—Gastrointestinal disorder—Irinotecan—colon cancer	0.000395	0.00275	CcSEcCtD
Midazolam—Fatigue—Irinotecan—colon cancer	0.000394	0.00274	CcSEcCtD
Midazolam—Paraesthesia—Fluorouracil—colon cancer	0.000393	0.00273	CcSEcCtD
Midazolam—Constipation—Irinotecan—colon cancer	0.000391	0.00272	CcSEcCtD
Midazolam—Pain—Irinotecan—colon cancer	0.000391	0.00272	CcSEcCtD
Midazolam—Dyspnoea—Fluorouracil—colon cancer	0.00039	0.00272	CcSEcCtD
Midazolam—Somnolence—Fluorouracil—colon cancer	0.000389	0.00271	CcSEcCtD
Midazolam—Immune system disorder—Capecitabine—colon cancer	0.000389	0.00271	CcSEcCtD
Midazolam—Mediastinal disorder—Capecitabine—colon cancer	0.000388	0.0027	CcSEcCtD
Midazolam—Chills—Capecitabine—colon cancer	0.000386	0.00269	CcSEcCtD
Midazolam—Dyspepsia—Fluorouracil—colon cancer	0.000385	0.00268	CcSEcCtD
Midazolam—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000378	0.00263	CcSEcCtD
Midazolam—Mental disorder—Capecitabine—colon cancer	0.000377	0.00262	CcSEcCtD
Midazolam—Feeling abnormal—Irinotecan—colon cancer	0.000377	0.00262	CcSEcCtD
Midazolam—Erythema—Capecitabine—colon cancer	0.000375	0.00261	CcSEcCtD
Midazolam—Pain—Fluorouracil—colon cancer	0.000374	0.0026	CcSEcCtD
Midazolam—Feeling abnormal—Fluorouracil—colon cancer	0.000361	0.00251	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—colon cancer	0.000357	0.00248	CcSEcCtD
Midazolam—Depression—Methotrexate—colon cancer	0.000356	0.00248	CcSEcCtD
Midazolam—Vision blurred—Capecitabine—colon cancer	0.000353	0.00246	CcSEcCtD
Midazolam—Tremor—Capecitabine—colon cancer	0.000351	0.00244	CcSEcCtD
Midazolam—Urticaria—Fluorouracil—colon cancer	0.000348	0.00242	CcSEcCtD
Midazolam—Hypersensitivity—Vincristine—colon cancer	0.000346	0.00241	CcSEcCtD
Midazolam—Vertigo—Capecitabine—colon cancer	0.000337	0.00234	CcSEcCtD
Midazolam—Hypersensitivity—Irinotecan—colon cancer	0.000337	0.00234	CcSEcCtD
Midazolam—Asthenia—Vincristine—colon cancer	0.000337	0.00234	CcSEcCtD
Midazolam—Syncope—Capecitabine—colon cancer	0.000336	0.00234	CcSEcCtD
Midazolam—Asthenia—Irinotecan—colon cancer	0.000328	0.00228	CcSEcCtD
Midazolam—Cough—Capecitabine—colon cancer	0.000327	0.00228	CcSEcCtD
Midazolam—Hypersensitivity—Fluorouracil—colon cancer	0.000323	0.00224	CcSEcCtD
Midazolam—Anxiety—Capecitabine—colon cancer	0.000318	0.00221	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000317	0.0022	CcSEcCtD
Midazolam—Dry mouth—Capecitabine—colon cancer	0.000312	0.00217	CcSEcCtD
Midazolam—CYP4B1—lymph node—colon cancer	0.000312	0.036	CbGeAlD
Midazolam—Dizziness—Vincristine—colon cancer	0.00031	0.00216	CcSEcCtD
Midazolam—Pruritus—Fluorouracil—colon cancer	0.00031	0.00215	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—colon cancer	0.000309	0.00215	CcSEcCtD
Midazolam—Confusional state—Capecitabine—colon cancer	0.000309	0.00215	CcSEcCtD
Midazolam—GABRB1—vagina—colon cancer	0.000303	0.035	CbGeAlD
Midazolam—Dizziness—Irinotecan—colon cancer	0.000302	0.0021	CcSEcCtD
Midazolam—Shock—Capecitabine—colon cancer	0.000301	0.00209	CcSEcCtD
Midazolam—Nervous system disorder—Capecitabine—colon cancer	0.0003	0.00209	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—colon cancer	0.0003	0.00208	CcSEcCtD
Midazolam—Tachycardia—Capecitabine—colon cancer	0.000299	0.00208	CcSEcCtD
Midazolam—Vomiting—Vincristine—colon cancer	0.000298	0.00208	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—colon cancer	0.000298	0.00207	CcSEcCtD
Midazolam—Skin disorder—Capecitabine—colon cancer	0.000297	0.00207	CcSEcCtD
Midazolam—Rash—Vincristine—colon cancer	0.000296	0.00206	CcSEcCtD
Midazolam—Dermatitis—Vincristine—colon cancer	0.000296	0.00206	CcSEcCtD
Midazolam—Headache—Vincristine—colon cancer	0.000294	0.00205	CcSEcCtD
Midazolam—Vomiting—Irinotecan—colon cancer	0.000291	0.00202	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—colon cancer	0.00029	0.00201	CcSEcCtD
Midazolam—Dizziness—Fluorouracil—colon cancer	0.00029	0.00201	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—colon cancer	0.000289	0.00201	CcSEcCtD
Midazolam—Rash—Irinotecan—colon cancer	0.000288	0.00201	CcSEcCtD
Midazolam—Dermatitis—Irinotecan—colon cancer	0.000288	0.002	CcSEcCtD
Midazolam—Chills—Methotrexate—colon cancer	0.000288	0.002	CcSEcCtD
Midazolam—CYP3A7—liver—colon cancer	0.000287	0.0332	CbGeAlD
Midazolam—Headache—Irinotecan—colon cancer	0.000286	0.00199	CcSEcCtD
Midazolam—Hypotension—Capecitabine—colon cancer	0.000286	0.00199	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—colon cancer	0.000281	0.00195	CcSEcCtD
Midazolam—Erythema—Methotrexate—colon cancer	0.000279	0.00194	CcSEcCtD
Midazolam—Nausea—Vincristine—colon cancer	0.000279	0.00194	CcSEcCtD
Midazolam—Vomiting—Fluorouracil—colon cancer	0.000278	0.00194	CcSEcCtD
Midazolam—Rash—Fluorouracil—colon cancer	0.000276	0.00192	CcSEcCtD
Midazolam—Dermatitis—Fluorouracil—colon cancer	0.000276	0.00192	CcSEcCtD
Midazolam—Paraesthesia—Capecitabine—colon cancer	0.000275	0.00191	CcSEcCtD
Midazolam—Headache—Fluorouracil—colon cancer	0.000274	0.00191	CcSEcCtD
Midazolam—Dyspnoea—Capecitabine—colon cancer	0.000273	0.0019	CcSEcCtD
Midazolam—SLC22A1—renal system—colon cancer	0.000273	0.0315	CbGeAlD
Midazolam—GABRP—vagina—colon cancer	0.000272	0.0314	CbGeAlD
Midazolam—Nausea—Irinotecan—colon cancer	0.000272	0.00189	CcSEcCtD
Midazolam—Dyspepsia—Capecitabine—colon cancer	0.000269	0.00187	CcSEcCtD
Midazolam—Gastrointestinal disorder—Capecitabine—colon cancer	0.000264	0.00184	CcSEcCtD
Midazolam—Fatigue—Capecitabine—colon cancer	0.000264	0.00183	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—colon cancer	0.000263	0.00183	CcSEcCtD
Midazolam—Constipation—Capecitabine—colon cancer	0.000262	0.00182	CcSEcCtD
Midazolam—Pain—Capecitabine—colon cancer	0.000262	0.00182	CcSEcCtD
Midazolam—Nausea—Fluorouracil—colon cancer	0.00026	0.00181	CcSEcCtD
Midazolam—Feeling abnormal—Capecitabine—colon cancer	0.000252	0.00175	CcSEcCtD
Midazolam—GABRR2—lymph node—colon cancer	0.000251	0.029	CbGeAlD
Midazolam—Vertigo—Methotrexate—colon cancer	0.000251	0.00174	CcSEcCtD
Midazolam—CYP3A7-CYP3A51P—liver—colon cancer	0.000244	0.0282	CbGeAlD
Midazolam—Cough—Methotrexate—colon cancer	0.000244	0.00169	CcSEcCtD
Midazolam—Urticaria—Capecitabine—colon cancer	0.000243	0.00169	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000236	0.00164	CcSEcCtD
Midazolam—Confusional state—Methotrexate—colon cancer	0.00023	0.0016	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—colon cancer	0.000228	0.00158	CcSEcCtD
Midazolam—Hypersensitivity—Capecitabine—colon cancer	0.000225	0.00157	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—colon cancer	0.000223	0.00155	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—colon cancer	0.000221	0.00154	CcSEcCtD
Midazolam—Asthenia—Capecitabine—colon cancer	0.00022	0.00153	CcSEcCtD
Midazolam—Pruritus—Capecitabine—colon cancer	0.000216	0.00151	CcSEcCtD
Midazolam—Hypotension—Methotrexate—colon cancer	0.000213	0.00148	CcSEcCtD
Midazolam—GABRA2—vagina—colon cancer	0.000209	0.0242	CbGeAlD
Midazolam—GABRE—vagina—colon cancer	0.000207	0.0239	CbGeAlD
Midazolam—Paraesthesia—Methotrexate—colon cancer	0.000205	0.00142	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—colon cancer	0.000203	0.00141	CcSEcCtD
Midazolam—Somnolence—Methotrexate—colon cancer	0.000203	0.00141	CcSEcCtD
Midazolam—Dizziness—Capecitabine—colon cancer	0.000202	0.00141	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—colon cancer	0.000201	0.00139	CcSEcCtD
Midazolam—SLC22A1—vagina—colon cancer	0.000197	0.0228	CbGeAlD
Midazolam—Gastrointestinal disorder—Methotrexate—colon cancer	0.000197	0.00137	CcSEcCtD
Midazolam—Fatigue—Methotrexate—colon cancer	0.000196	0.00137	CcSEcCtD
Midazolam—Pain—Methotrexate—colon cancer	0.000195	0.00135	CcSEcCtD
Midazolam—ABCB1—blood vessel—colon cancer	0.000195	0.0225	CbGeAlD
Midazolam—Vomiting—Capecitabine—colon cancer	0.000195	0.00135	CcSEcCtD
Midazolam—Rash—Capecitabine—colon cancer	0.000193	0.00134	CcSEcCtD
Midazolam—Dermatitis—Capecitabine—colon cancer	0.000193	0.00134	CcSEcCtD
Midazolam—Headache—Capecitabine—colon cancer	0.000192	0.00133	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—colon cancer	0.000188	0.00131	CcSEcCtD
Midazolam—Nausea—Capecitabine—colon cancer	0.000182	0.00126	CcSEcCtD
Midazolam—Urticaria—Methotrexate—colon cancer	0.000181	0.00126	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—colon cancer	0.000168	0.00117	CcSEcCtD
Midazolam—SLC22A1—liver—colon cancer	0.000167	0.0192	CbGeAlD
Midazolam—CYP3A5—renal system—colon cancer	0.000166	0.0191	CbGeAlD
Midazolam—CYP2B6—renal system—colon cancer	0.000165	0.019	CbGeAlD
Midazolam—Asthenia—Methotrexate—colon cancer	0.000163	0.00114	CcSEcCtD
Midazolam—Pruritus—Methotrexate—colon cancer	0.000161	0.00112	CcSEcCtD
Midazolam—CYP2E1—renal system—colon cancer	0.000154	0.0178	CbGeAlD
Midazolam—Dizziness—Methotrexate—colon cancer	0.000151	0.00105	CcSEcCtD
Midazolam—GABRB3—liver—colon cancer	0.000148	0.0171	CbGeAlD
Midazolam—Vomiting—Methotrexate—colon cancer	0.000145	0.00101	CcSEcCtD
Midazolam—Rash—Methotrexate—colon cancer	0.000144	0.000999	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—colon cancer	0.000143	0.000998	CcSEcCtD
Midazolam—Headache—Methotrexate—colon cancer	0.000143	0.000993	CcSEcCtD
Midazolam—CYP2B6—lymphoid tissue—colon cancer	0.000137	0.0158	CbGeAlD
Midazolam—CYP3A5—digestive system—colon cancer	0.000136	0.0157	CbGeAlD
Midazolam—Nausea—Methotrexate—colon cancer	0.000135	0.000941	CcSEcCtD
Midazolam—GABRA2—lymph node—colon cancer	0.000135	0.0156	CbGeAlD
Midazolam—CYP2B6—digestive system—colon cancer	0.000135	0.0156	CbGeAlD
Midazolam—GABRE—lymph node—colon cancer	0.000134	0.0155	CbGeAlD
Midazolam—CYP2E1—lymphoid tissue—colon cancer	0.000128	0.0148	CbGeAlD
Midazolam—CYP2E1—digestive system—colon cancer	0.000127	0.0146	CbGeAlD
Midazolam—CYP3A4—renal system—colon cancer	0.000124	0.0143	CbGeAlD
Midazolam—CYP3A5—vagina—colon cancer	0.00012	0.0138	CbGeAlD
Midazolam—CYP2B6—vagina—colon cancer	0.000119	0.0138	CbGeAlD
Midazolam—ABCB1—embryo—colon cancer	0.000116	0.0134	CbGeAlD
Midazolam—CYP3A4—digestive system—colon cancer	0.000102	0.0118	CbGeAlD
Midazolam—CYP3A5—liver—colon cancer	0.000101	0.0117	CbGeAlD
Midazolam—CYP2B6—liver—colon cancer	0.000101	0.0116	CbGeAlD
Midazolam—ABCB1—epithelium—colon cancer	9.48e-05	0.0109	CbGeAlD
Midazolam—CYP2E1—liver—colon cancer	9.43e-05	0.0109	CbGeAlD
Midazolam—ABCB1—renal system—colon cancer	8.79e-05	0.0102	CbGeAlD
Midazolam—CYP3A4—liver—colon cancer	7.59e-05	0.00877	CbGeAlD
Midazolam—ABCB1—lymphoid tissue—colon cancer	7.3e-05	0.00843	CbGeAlD
Midazolam—ABCB1—digestive system—colon cancer	7.21e-05	0.00833	CbGeAlD
Midazolam—ABCB1—bone marrow—colon cancer	6.65e-05	0.00768	CbGeAlD
Midazolam—ABCB1—vagina—colon cancer	6.37e-05	0.00736	CbGeAlD
Midazolam—Ketazolam—ABCB1—colon cancer	6.01e-05	0.313	CrCbGaD
Midazolam—ABCB1—liver—colon cancer	5.37e-05	0.00621	CbGeAlD
Midazolam—Clobazam—ABCB1—colon cancer	4.25e-05	0.221	CrCbGaD
Midazolam—ABCB1—lymph node—colon cancer	4.12e-05	0.00476	CbGeAlD
Midazolam—Chlorprothixene—ABCB1—colon cancer	3.34e-05	0.174	CrCbGaD
Midazolam—Flurazepam—ABCB1—colon cancer	3.12e-05	0.163	CrCbGaD
Midazolam—Diazepam—ABCB1—colon cancer	2.48e-05	0.129	CrCbGaD
